Although several phytochemicals that can inhibit the MEK-ERK pathway have been suggested as potential cancer drugs [25], MEK-ERK-dependent multiple caspase activation is essential for mouse fibroblast and glioma cell death [26,27]. This evidence concerns the gene MAP2K7 and central nervous system cancer.